Immune Therapeutics OTC Stock Forecast - Polynomial Regression

IMUN -  USA Stock  

USD 1.50  0.25  14.29%

Immune OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Immune Therapeutics historical stock prices and determine the direction of Immune Therapeutics's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Immune Therapeutics historical fundamentals such as revenue growth or operating cash flow patterns.
Please see Historical Fundamental Analysis of Immune Therapeutics to cross-verify your projections.

Immune O TC Stock Forecast 

 
Refresh
Most investors in Immune Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Immune Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Immune Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Immune Therapeutics polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Immune Therapeutics as well as the accuracy indicators are determined from the period prices.

Immune Therapeutics Polynomial Regression Price Forecast For the 10th of December

Given 90 days horizon, the Polynomial Regression forecasted value of Immune Therapeutics on the next trading day is expected to be 1.34 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.09, and the sum of the absolute errors of 13.74. Please note that although there have been many attempts to predict Immune OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Immune Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Immune Therapeutics OTC Stock Forecast Pattern

Backtest Immune TherapeuticsImmune Therapeutics Price PredictionBuy or Sell Advice 

Immune Therapeutics Forecasted Value

In the context of forecasting Immune Therapeutics' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Immune Therapeutics' downside and upside margins for the forecasting period are 0.015 and 14.95, respectively. We have considered Immune Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.50
9th of December 2021
1.34
Expected Value
14.95
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Immune Therapeutics otc stock data series using in forecasting. Note that when a statistical model is used to represent Immune Therapeutics otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.694
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2253
MAPEMean absolute percentage error0.0947
SAESum of the absolute errors13.7406
A single variable polynomial regression model attempts to put a curve through the Immune Therapeutics historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Immune Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immune Therapeutics. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immune Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immune Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.081.5015.12
Details
Intrinsic
Valuation
LowReal ValueHigh
0.071.4415.06
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.202.072.94
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immune Therapeutics. Your research has to be compared to or analyzed against Immune Therapeutics' peers to derive any actionable benefits. When done correctly, Immune Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immune Therapeutics.

Other Forecasting Options for Immune Therapeutics

For every potential investor in Immune, whether a beginner or expert, Immune Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immune OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immune. Basic forecasting techniques help filter out the noise by identifying Immune Therapeutics' price trends.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immune Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Immune Therapeutics could also be used in its relative valuation, which is a method of valuing Immune Therapeutics by comparing valuation metrics with similar companies.

Immune Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Immune Therapeutics' price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Immune Therapeutics' current price.

Immune Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Immune Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immune Therapeutics shares will generate the highest return on investment. By undertsting and applying Immune Therapeutics otc stock market strength indicators, traders can identify Immune Therapeutics entry and exit signals to maximize returns.

Immune Therapeutics Risk Indicators

The analysis of Immune Therapeutics' basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in Immune Therapeutics' investment and either accepting that risk or mitigating it. Along with some funamental techniques of forecasting Immune Therapeutics stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Immune Therapeutics Investors Sentiment

The influence of Immune Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immune. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immune Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immune Therapeutics' short interest history, or implied volatility extrapolated from Immune Therapeutics options trading.

Current Sentiment - IMUN

Immune Therapeutics Investor Sentiment

Most of Macroaxis users are currently bullish on Immune Therapeutics. What is your judgment towards investing in Immune Therapeutics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immune Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Historical Fundamental Analysis of Immune Therapeutics to cross-verify your projections. Note that the Immune Therapeutics information on this page should be used as a complementary analysis to other Immune Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Immune OTC Stock analysis

When running Immune Therapeutics price analysis, check to measure Immune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immune Therapeutics is operating at the current time. Most of Immune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Immune Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immune Therapeutics' price. Additionally, you may evaluate how the addition of Immune Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Immune Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immune Therapeutics. If investors know Immune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immune Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immune Therapeutics is measured differently than its book value, which is the value of Immune that is recorded on the company's balance sheet. Investors also form their own opinion of Immune Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Immune Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immune Therapeutics' market value can be influenced by many factors that don't directly affect Immune Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immune Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immune Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immune Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.